Johnson & Johnson vs Medpace Holdings, Inc.
JNJ vs MEDP — side-by-side comparison from reported financials. JNJ leads 6, MEDP leads 3 of 9 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
Medpace Holdings, Inc.
MEDP · Healthcare
$612.05+1.55%Strained
| Metric | JNJ | MEDP |
|---|---|---|
| Price | $261.79 | $612.05 |
| Market cap | $631B | $17.1B |
| Revenue (TTM) | $97.9B | $2.78B |
| Revenue growth | +5.6% | +20.1% |
| Net margin | 21.5% | 17.7% |
| Free cash flow | $22.2B | $707M |
| Net cash (debt) | ($27.8B) | — |
| 1-year price return | +37.0% | +18.0% |
| P/E | 29.9 | 34.8 |
| P/E vs own history (cheap-side %) | 16% | 30% |
| Dividend yield | 2.00% | — |
| Return on equity | 26% | 110% |
| CV checks passed | 10 of 11 | 8 of 11 |
| Employees | 140,800 | 6,500 |
Full résumé-style profiles: JNJ CV · MEDP CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.